Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Hepatic Fibrosis in Patients With Type 2 Diabetes: A Chart-Based Analysis

Journal of Endocrinology and Metabolism- Canada

doi 10.14740/jem632

Full Text

Abstract

Available in

Categories

Date

January 1, 2020

Authors

Hisayuki Katsuyama

Mariko Hakoshima

Takehiro Iijima

Hidekatsu Yanai

Publisher

Elmer Press, Inc.

Related search

Sodium–Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes

Internal Medicine

Specialized Nursing

English

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Urinary Excretion of Intact and Total Angiotensinogen in Patients With Type 2 Diabetes

Journal of Investigative Medicine

Molecular Biology

English

Effects of Sodium Glucose Cotransporter Type 2 Inhibitors on Heart Failure

Diabetes, Obesity and Metabolism

Internal Medicine

English

Cardiovascular Effects of Sodium Glucose Cotransporter 2 Inhibitors

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Internal Medicine

English

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors

Journal of Clinical Medicine Research

English

Use of Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections in Type 2 Diabetes Patients: A Systematic Review

Revista da Associacao Medica Brasileira

English

Early Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes: Study Based on Continuous Glucose Monitoring

Diabetology and Metabolic Syndrome

Internal Medicine

English

Heart Failure Prevention With Sodium‐glucose Cotransporter 2 Inhibitors

Journal of Diabetes

English

Renal Glucose Handling: Impact of Chronic Kidney Disease and Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes

Internal Medicine

Specialized Nursing

English